Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ACFER01 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::2304645636.png) ACF Equity Research [@ACFER01](/creator/twitter/ACFER01) on x 2034 followers
Created: 2023-02-08 11:30:43 UTC

#hVIVOplc AIM: $HVO; IR: $HVO ▲27%, signs £6.8m contract w/ an APAC pharma co. to test #HVO respiratory syncytial virus - antiviral drug candidate - using #hVIVO RSV Human Challenge Study Model. Read our #ACFInsight on vaccines @hVIVO_UK

![](https://pbs.twimg.com/media/FocPYaGXoAIKFZM.jpg)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1623283179795644422/c:line.svg)

**Related Topics**
[$hvo](/topic/$hvo)

[Post Link](https://x.com/ACFER01/status/1623283179795644422)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ACFER01 Avatar ACF Equity Research @ACFER01 on x 2034 followers Created: 2023-02-08 11:30:43 UTC

#hVIVOplc AIM: $HVO; IR: $HVO ▲27%, signs £6.8m contract w/ an APAC pharma co. to test #HVO respiratory syncytial virus - antiviral drug candidate - using #hVIVO RSV Human Challenge Study Model. Read our #ACFInsight on vaccines @hVIVO_UK

XX engagements

Engagements Line Chart

Related Topics $hvo

Post Link

post/tweet::1623283179795644422
/post/tweet::1623283179795644422